Sponsors (2)
Defines fentanyl-related substances broadly in federal Schedule I and removes mandatory minimum prison terms for offenses involving those substances.
The bill trades reduced mandatory minimum sentencing and clearer statutory definitions for fentanyl-related substances—potentially lowering incarceration and easing classification—against expanded Schedule I coverage that could hinder research, raise compliance costs, create legal uncertainty, and weaken certain prosecutorial deterrents.
People prosecuted for fentanyl-analog possession or distribution would no longer face mandatory minimum prison terms under §841(b)(1)(C) for substances covered by the new definition, giving judges more discretion and likely reducing incarceration for low-level offenders (and associated taxpayer costs).
DEA and law-enforcement would have a broad statutory definition to categorize fentanyl-related substances uniformly, simplifying scheduling decisions and reducing some ambiguity in enforcement and classification.
Scientists, researchers, and patients would face tighter restrictions because many structural analogs placed automatically in Schedule I would impede medical research and clinical access, increasing regulatory burdens and slowing development of potentially beneficial therapies.
Scientists, labs, and small manufacturers could be criminalized for novel or trace compounds—broad language that schedules many structural analogs risks expanding enforcement scope and creating legal uncertainty (including for inadvertent contamination).
Small labs and manufacturers would face higher compliance costs and greater exposure to civil or criminal penalties because broad scheduling could trigger more DEA enforcement actions and prosecutorial discretion.
Based on analysis of 2 sections of legislative text.
Official title: To amend the Controlled Substances Act to list fentanyl-related substances as schedule I controlled substances, and for other purposes.
Introduced February 4, 2025 by Vernon G. Buchanan · Last progress February 4, 2025
Creates a broad statutory definition of “fentanyl-related substances” by adding a new Schedule I subsection that covers materials containing fentanyl analogs and several classes of structural modifications. Separately, it removes the federal mandatory minimum prison terms that would otherwise apply to offenses involving substances that meet that new definition, changing sentencing exposure for federal fentanyl-related prosecutions.